What Caused The Opening Gap In Deciphera Pharmaceuticals?

For real-time updates on DCPH, beat the news and login or try Benzinga Pro.

Deciphera Pharmaceuticals DCPH today had a large opening gap of 53.50%.

Photo taken from the Opening Gap Signals tool inside Benzinga Pro.

Why Is DCPH Moving?

Deciphera Pharmaceuticals shares are trading higher after the company reported a positive update that its Phase 1 Data for Ripretinib in gastrointestinal stromal tumors achieved primary endpoint.

Photo taken from the ‘Why Is It Moving?’ Details tool inside Benzinga Pro.

For live updates on DCPH, log in or try Benzinga Pro today.

Posted In: BiotechNewsIntraday UpdateGeneral
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...